In conclusion, considering the increased CMT measurements in GDM patients withelevated HbA1c levels along with elevated BMI and high insulin use rates, thesepatients may be at an increased risk of developing T2DM in future. The gene discussed is INS; the disease is type 2 diabetes mellitus.